Xiaohu Deng

USPTO Granted Patents = 22 (Patent Applications = 5)

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 69(Granted Patents)

Company Filing History:

13 out of 2,076

Janssen Pharmaceutica Nv

patents

3 out of 4

Viracta Subsidiary, Inc.

patents

3 out of 363

Ortho-mcneil Pharmaceutical Corp.

Years Active: 2007-2025

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410184 - Crystalline forms of a menin inhibitor (2025-09-09),

2. 12012396 - HDAC inhibitor solid state forms (2024-06-18),

3. 11780822 - HDAC inhibitor solid state forms (2023-10-10),

4. 11760748 - HDAC inhibitor solid state forms (2023-09-19),

5. 11542244 - Synthesis of tipifarnib (2023-01-03),

6. 10112937 - P2X7 modulators and methods of use (2018-10-30),

7. 9988357 - Methods for preparation of quinazoline derivatives (2018-06-05),

8. 8598202 - Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase (2013-12-03),

9. 8242273 - Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine (2012-08-14),

10. 8124765 - Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine (2012-02-28),

11. 8071782 - Synthesis of 1,3,4-trisubstituted and 1,3,4,5-tetrasubstituted pyrazoles (2011-12-06),

12. 7947833 - Preparation of quinoxaline compounds (2011-05-24),

13. 7939527 - Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase (2011-05-10),

14. 7915404 - Methods for the preparation of pyrazole-containing compounds (2011-03-29),

15. 7897771 - Fused heterocyclic compounds (2011-03-01),

Title: Innovations and Contributions of Xiaohu Deng in Drug Development

Introduction

Xiaohu Deng is a renowned inventor based in San Diego, California, known for his significant contributions to the pharmaceutical industry. With an impressive portfolio of 21 patents, he has made remarkable strides in the development of innovative therapies for treating cancer, immune disorders, and inflammation.

Latest Patents

Deng's recent patents include groundbreaking work on HDAC inhibitor solid-state forms. These patents detail the crystalline mesylate Form 1 salt of N-hydroxy 2-{6-[(6-fluoro-quinolin-2-ylmethyl)-amino]-3-aza-bicyclo[3.1.0]hex-3-yl}pyrimidine-5-carboxamide, providing essential methods of making this compound. Such formulations are pivotal in creating effective pharmaceutical compositions, aimed at treating various health conditions, including cancer and immune-related disorders.

Career Highlights

Throughout his career, Xiaohu Deng has collaborated with leading companies in the pharmaceutical sector, including Janssen Pharmaceutica NV and Ortho-McNeil Pharmaceutical Corporation. His work at these organizations has not only advanced drug development but also contributed to the scientific community's understanding of complex medical conditions.

Collaborations

Deng has worked alongside prominent colleagues such as Neelakandha S. Mani and Jimmy T. Liang. These partnerships have played a crucial role in fostering a collaborative environment, ensuring that innovative ideas transition effectively from research to application.

Conclusion

Xiaohu Deng's contributions to the field of pharmaceuticals through his patents showcase the importance of innovation in medicine. His ongoing efforts to develop effective treatments highlight the critical role inventors play in advancing healthcare solutions for challenging diseases. The impact of his work is expected to resonate in the industry, inspiring future innovations.

This text is generated by artificial intelligence and may not be accurate.